Globalpharma Co LLC

About Globalpharma Co LLC

Globalpharma is a wholly owned subsidiary of Dubai Investments PJSC. Established in 1998, Global pharma is currently a market leader in key generic pharma segments with a strong regional footprint. Globalpharma started its operations in the UAE in 2003 and expanded its growth in 2008 with product line extensions and New product launches across 14 countries in the GCC and select African markets. Currently, Global pharma has two Manufacturing plants, A state of the art Beta-Lactam Penicillin Manufacturing plant providing the Amoxicillin & AmoxiClav brands in the larger MENA region. Additionally, catering to the Lifestyle disease segments is a General Medicine Manufacturing Plant with a variety of Liquid & Oral Solid Dose capabilities. Globalpharma’s manufacturing facilities are cGMP certified, and approved by all health authorities in the Middle-East, Levant, Africa, and CIS regions.